Results 41 to 50 of about 5,625 (214)
Dapsone induced cholangitis as a part of dapsone syndrome: a case report
BMC Gastroenterology, 2003 Background Dapsone can rarely cause a hypersensitivity reaction called dapsone syndrome, consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia.
Choudhuri Gourdas +3 more
doaj +1 more source
Exclusions affect representativeness of Alzheimer's disease trial participants
Alzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 1, January/March 2026.Abstract BACKGROUND This study assessed how medical exclusion criteria of a prevention Alzheimer's disease trial impact potential eligibility and sample characteristics. METHODS Medical exclusion criteria from the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial were applied to N = 3695 participants from the population‐based Health
Miriam T. Ashford +6 more
wiley +1 more source
Hemodialysis International, Volume 30, Issue 1, Page 80-100, January 2026.ABSTRACT Introduction Erythropoiesis‐stimulating agents (ESAs) and iron supplementation are standard treatments for chronic kidney disease (CKD)–related anemia. Targeting higher hemoglobin values in CKD increases cardiovascular risk. Whether the increased risk is from higher ESA doses or higher hemoglobin levels is uncertain, but alternative therapies ...
Alan Jardine +9 more
wiley +1 more source
The Study of Clinical , Pathological and Laboratory Finding of Forty-Eghit Erythroderma Patients
پزشکی بالینی ابن سینا, 2000 Erythroderma is a term applied to any inflammatory skin disease which affects more than about 90% of the body surface. It is determined by erythema, scaling and pruritus.
Mahmoud Farshchian +2 more
doaj
Erythroderma: A clinico-etiological study of 58 cases in a tertiary hospital of North India
Asian Journal of Medical Sciences, 2015 Background: Erythroderma (exfoliative dermatitis) is a cutaneous reaction pattern characterized by generalized erythema and scaling which can be seen in a wide range of cutaneous or systemic diseases.
Nadia Shirazi
doaj +1 more source
Amiodarone-induced skin lesions
Клинический разбор в общей медицине, 2023 An important component of rational pharmacotherapy is drug safety – one of the priority basic areas of modern medicine and pharmacy. Often, the presence of side effects of a drug, despite its effectiveness, is an obstacle to its use or requires careful ...
Dmitry I. Trukhan +2 more
doaj +1 more source
A child with persistent exfoliative dermatitis [PDF]
, 2023 Cherlyn Yue Lin Chin +2 more
openalex +1 more source
CA: A Cancer Journal for Clinicians, Volume 75, Issue 5, Page 436-460, September/October 2025.Abstract High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer, accounting for approximately 70% of all ovarian cancer cases and contributing significantly to the high mortality rates associated with this disease.
Pawel Kordowitzki +6 more
wiley +1 more source
Chronic Diseases and Translational Medicine, Volume 11, Issue 3, Page 173-185, September 2025.The interaction of tislelizumab with PD‐1/PD‐L1 in the tumor microenvironment. Tislelizumab targets PD‐1 on T cells, blocking its interaction with PD‐L1 on tumor cells. This action is facilitated by a modified F(ab) region that limits Fc‐γ receptor binding, thereby enhancing the antitumor immune response. ABSTRACT Tislelizumab is a next‐generation PD‐1
Thy T. Nguyen +4 more
wiley +1 more source
PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma
Cancer Science, Volume 116, Issue 8, Page 2189-2197, August 2025.CITADEL‐213 evaluated the efficacy and safety of parsaclisib (PI3Kδ inhibitor) in Japanese patients with relapsed or refractory follicular lymphoma (R/R FL). The objective response rate was 88.1%, with 23.8% of patients experiencing a complete response and 64.3% experiencing a partial response; treatment‐emergent adverse events led to parsaclisib ...
Noriko Fukuhara +15 more
wiley +1 more source